Latest Parkman Healthcare Partners LLC Stock Portfolio

Parkman Healthcare Partners LLC Performance:

2025 Q4: 10.19%YTD: 22.7%2024: 8.91%

Performance for 2025 Q4 is 10.19%, and YTD is 22.7%, and 2024 is 8.91%.

About Parkman Healthcare Partners LLC and 13F Hedge Fund Stock Holdings

Parkman Healthcare Partners LLC is a hedge fund based in Stamford, CT. On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, Parkman Healthcare Partners LLC reported an equity portfolio of $1.1 Billions as of 31 Dec, 2025.

The top stock holdings of Parkman Healthcare Partners LLC are BSX, PODD, DXCM. The fund has invested 4.5% of it's portfolio in BOSTON SCIENTIFIC CORP and 3.8% of portfolio in INSULET CORP.

The fund managers got completely rid off UNITED THERAPEUTICS CORP DEL (UTHR), INCYTE CORP (INCY) and ASCENDIS PHARMA A/S (ASND) stocks. They significantly reduced their stock positions in BUTTERFLY NETWORK INC (BFLY), TREACE MED CONCEPTS INC (TMCI) and TRAVERE THERAPEUTICS INC (TVTX). Parkman Healthcare Partners LLC opened new stock positions in MASIMO CORP (MASI), EYEPOINT INC (EYPT) and WATERS CORP (WAT). The fund showed a lot of confidence in some stocks as they added substantially to DEXCOM INC (DXCM), 4D MOLECULAR THERAPEUTICS IN (FDMT) and DAY ONE BIOPHARMACEUTICALS I (DAWN).

Parkman Healthcare Partners LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Parkman Healthcare Partners LLC made a return of 10.19% in the last quarter. In trailing 12 months, it's portfolio return was 22.7%.

Performance
S&P 500

New Buys

Ticker	$ Bought
masimo corp	26,012,000
eyepoint inc	19,878,400
waters corp	15,914,500
mettler toledo international	15,319,400
agilent technologies inc	13,607,000
ani pharmaceuticals inc	11,446,300
unitedhealth group inc	10,522,300
adaptive biotechnologies cor	6,524,100

New stocks bought by Parkman Healthcare Partners LLC

Additions

Ticker	% Inc.
dexcom inc	242
4d molecular therapeutics in	151
day one biopharmaceuticals i	113
stoke therapeutics inc	72.06
stryker corporation	64.52
livanova plc	48.98
arcus biosciences inc	48.4
annexon inc	48.1

Additions to existing portfolio by Parkman Healthcare Partners LLC

Reductions

Ticker	% Reduced
butterfly network inc	-83.26
treace med concepts inc	-76.48
travere therapeutics inc	-74.6
biogen inc	-72.78
crinetics pharmaceuticals in	-69.00
castle biosciences inc	-68.34
rapid micro biosystems inc	-61.19
alphatec hldgs inc	-60.23

Parkman Healthcare Partners LLC reduced stake in above stock

Sold off

Ticker	$ Sold
outset med inc	-6,417,710
dynavax technologies corp	-2,694,070
biomarin pharmaceutical inc	-6,821,400
incyte corp	-8,518,490
908 devices inc	-879,224
tvardi therapeutics inc	-2,533,050
abivax sa	-4,686,220
ascendis pharma a/s	-8,020,590

Parkman Healthcare Partners LLC got rid off the above stocks

Sector Distribution

Parkman Healthcare Partners LLC has about 84.8% of it's holdings in Healthcare sector.

Sector	%
Healthcare	84.8
Others	14.7

Market Cap. Distribution

Parkman Healthcare Partners LLC has about 37.1% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	37.1
MID-CAP	23.7
SMALL-CAP	21.5
UNALLOCATED	14.7
MICRO-CAP	2

Stocks belong to which Index?

About 71.5% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
RUSSELL 2000	37.9
S&P 500	33.6
Others	28.5

Top 5 Winners (%)		%
TERN	terns pharmaceuticals inc	364.4 %
AGLE	spyre therapeutics inc	77.3 %
FOLD	amicus therapeutics inc	75.9 %
	apogee therapeutics inc	75.3 %
IMNM	immunome inc	74.7 %

Top 5 Winners ($)		$
TERN	terns pharmaceuticals inc	25.6 M
	mbx biosciences inc	11.6 M
FOLD	amicus therapeutics inc	10.1 M
VRDN	viridian therapeutics inc	9.3 M
RCUS	arcus biosciences inc	8.3 M

Top 5 Losers (%)		%
QURE	uniqure nv	-51.5 %
OPRX	optimizerx corp	-39.5 %
TMCI	treace med concepts inc	-39.2 %
DOCS	doximity inc	-37.6 %
AGIO	agios pharmaceuticals inc	-32.1 %

Top 5 Losers ($)		$
QURE	uniqure nv	-10.4 M
DOCS	doximity inc	-4.9 M
OPRX	optimizerx corp	-4.3 M
ALNY	alnylam pharmaceuticals inc	-4.0 M
PODD	insulet corp	-3.1 M

Parkman Healthcare Partners LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Parkman Healthcare Partners LLC

Parkman Healthcare Partners LLC has 100 stocks in it's portfolio. About 32.3% of the portfolio is in top 10 stocks. QURE proved to be the most loss making stock for the portfolio. TERN was the most profitable stock for Parkman Healthcare Partners LLC last quarter.

Last Reported on: 17 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
A	agilent technologies inc	1.29	100,000	13,607,000	new

ABSI	absci corporation	0.48	1,458,650	5,090,700	new

ACHC	acadia healthcare company in	0.14	100,000	1,419,000	new

ACLX	arcellx inc	0.80	128,111	8,352,840	reduced	-14.51

ADMA	adma biologics inc	0.35	200,000	3,648,000	new

ADPT	adaptive biotechnologies cor	0.62	401,730	6,524,100	new

AGIO	agios pharmaceuticals inc	0.26	99,604	2,711,220	reduced	-0.77

AGLE	spyre therapeutics inc	0.39	124,485	4,078,130	reduced	-37.99

ALGN	align technology inc	0.38	25,285	3,948,250	new

ALNY	alnylam pharmaceuticals inc	1.81	47,703	18,969,100	reduced	-45.6

AMLX	amylyx pharmaceuticals inc	0.44	381,760	4,611,660	reduced	-34.09

ANIP	ani pharmaceuticals inc	1.09	145,000	11,446,300	new

ANNX	annexon inc	0.29	601,202	3,018,030	added	48.1

AORT	artivion inc	0.95	218,669	9,973,490	reduced	-1.07

ARAY	accuray inc	0.07	852,012	702,569	new

ASMB	assembly biosciences inc	0.81	249,357	8,480,630	reduced	-0.65

ASND	ascendis pharma a/s	0.00	0.00	0.00	sold off	-100

ATEC	alphatec hldgs inc	0.56	277,181	5,831,890	reduced	-60.23

AXGN	axogen inc	0.78	250,318	8,192,910	reduced	-50.12

BCRX	biocryst pharmaceuticals inc	0.67	900,057	7,020,440	reduced	-11.12